These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 22234564)
1. [Assessment of the strategies to improve therapeutic compliance in routine clinical practice in noncompliant patients with Alzheimer-type dementia]. Molinuevo JL; Arranz FJ Rev Neurol; 2012 Jan; 54(2):65-73. PubMed ID: 22234564 [TBL] [Abstract][Full Text] [Related]
2. Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer's disease. Molinuevo JL; Arranz FJ Expert Rev Neurother; 2012 Jan; 12(1):31-7. PubMed ID: 22243044 [TBL] [Abstract][Full Text] [Related]
3. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)]. Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995 [TBL] [Abstract][Full Text] [Related]
4. Predictors of adherence among Alzheimer's disease patients receiving oral therapy. Borah B; Sacco P; Zarotsky V Curr Med Res Opin; 2010 Aug; 26(8):1957-65. PubMed ID: 20569067 [TBL] [Abstract][Full Text] [Related]
5. [Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease]. Molinuevo JL; Hernández B; Neurologia; 2011 Nov; 26(9):518-27. PubMed ID: 21803459 [TBL] [Abstract][Full Text] [Related]
6. A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study. Gauthier S; Juby A; Morelli L; Rehel B; Schecter R; Curr Med Res Opin; 2006 Nov; 22(11):2251-65. PubMed ID: 17076986 [TBL] [Abstract][Full Text] [Related]
7. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease. Monsch AU; Giannakopoulos P; Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752 [TBL] [Abstract][Full Text] [Related]
8. Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study. de Rotrou J; Cantegreil I; Faucounau V; Wenisch E; Chausson C; Jegou D; Grabar S; Rigaud AS Int J Geriatr Psychiatry; 2011 Aug; 26(8):833-42. PubMed ID: 20922772 [TBL] [Abstract][Full Text] [Related]
9. Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease. Clipp EC; Moore MJ Clin Pharmacol Ther; 1995 Aug; 58(2):228-36. PubMed ID: 7648773 [TBL] [Abstract][Full Text] [Related]
10. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease. Hashimoto M; Yatabe Y; Kaneda K; Honda K; Ikeda M Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821 [TBL] [Abstract][Full Text] [Related]
11. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey. Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121 [TBL] [Abstract][Full Text] [Related]
12. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials? Cortes F; Portet F; Touchon J; Vellas B J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease treatment: assessing caregiver preferences for mode of treatment delivery. Abetz L; Rofail D; Mertzanis P; Heelis R; Rosa K; Tellefsen C; Roborel de Climens A; McBurney C; Thomas S Adv Ther; 2009 Jun; 26(6):627-44. PubMed ID: 19495575 [TBL] [Abstract][Full Text] [Related]
14. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846 [TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
16. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden]. Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367 [TBL] [Abstract][Full Text] [Related]
17. Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE). Gauthier S; Juby A; Dalziel W; Réhel B; Schecter R; Curr Med Res Opin; 2010 May; 26(5):1149-60. PubMed ID: 20230208 [TBL] [Abstract][Full Text] [Related]
18. Caregiver characteristics are associated with neuropsychiatric symptoms of dementia. Sink KM; Covinsky KE; Barnes DE; Newcomer RJ; Yaffe K J Am Geriatr Soc; 2006 May; 54(5):796-803. PubMed ID: 16696746 [TBL] [Abstract][Full Text] [Related]
19. Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease. Blesa R; Ballard C; Orgogozo JM; Lane R; Thomas SK Neurology; 2007 Jul; 69(4 Suppl 1):S23-8. PubMed ID: 17646620 [TBL] [Abstract][Full Text] [Related]
20. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach. Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]